Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer

被引：1
|
作者：
Havard, Robert [1 ]
Henry, N. Lynn [1 ]
机构：
[1] Univ Utah, Dept Internal Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 28期
关键词：
21 gene recurrence score; 70 gene signature; breast cancer; chemotherapy; multiparameter genomic assays; prediction; prognosis; ADJUVANT SYSTEMIC THERAPY; AMERICAN SOCIETY; GENE-EXPRESSION; GUIDE DECISIONS; WOMEN; VALIDATION; SIGNATURE; BIOMARKERS; ASSAY;
D O I：
10.2217/fon-2017-0452
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2507 / 2510
页数：4
相关论文
共 50 条
  • [1] Genomic Molecular Profiling in Breast Cancer: Transforming Radiation Decision-Making Through Precision Medicine
    Abou Zeidane, Reine
    Lichtman-Mikol, Samuel
    Speers, Corey
    CURRENT BREAST CANCER REPORTS, 2025, 17 (01)
  • [2] Decision-making in early breast cancer: guidelines and decision tools
    Baum, M
    Ravdin, PM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (06) : 745 - 749
  • [3] Distribution and influence of the 21-gene recurrence score on chemotherapy decision-making in special type of breast cancer
    Yu, Jing
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6188 - +
  • [4] Exploring and supporting older women's chemotherapy decision-making in early-stage breast cancer
    Karuturi, Meghan S.
    Giordano, Sharon H.
    Hoover, Diana S.
    Volk, Robert J.
    Housten, Ashley J.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (02) : 170 - 175
  • [5] The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer
    Bar, Yael
    Bar, Kfir
    Itzhak, Itay
    Niselbaum, Chen Shitrit
    Dershowitz, Nachum
    Shachar, Eliya
    Weiss-Meilik, Ahuva
    Golan, Orit
    Wolf, Ido
    Menes, Tehillah
    Sonnenblick, Amir
    BREAST, 2021, 60 : 78 - 85
  • [6] The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy
    MacDonald, Karen V.
    Bombard, Yvonne
    Deal, Ken
    Trudeau, Maureen
    Leighl, Natasha
    Marshall, Deborah A.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : 85 - 93
  • [7] Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing
    Fallowfield, Lesley
    Matthews, Lucy
    May, Shirley
    Jenkins, Valerie
    Bloomfield, David
    PSYCHO-ONCOLOGY, 2018, 27 (04) : 1264 - 1269
  • [8] Cost-utility analysis of genomic profiling in early breast cancer in Colombia
    Rojas, Leonardo
    Rojas-Reyes, Maria X.
    Rosselli, Diego
    Ariza, Juan Guillermo
    Ruiz-Patino, Alejandro
    Cardona, Andres F.
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [9] Decision-making tools to assist prognosis and treatment choices in early breast cancer: a review
    Al-Allak, Asmaa
    Lewis, Paul D.
    Bertelli, Gianfilippo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (08) : 1033 - 1043
  • [10] Online accounts of gene expression profiling in early-stage breast cancer: Interpreting genomic testing for chemotherapy decision making
    Ross, Emily
    Swallow, Julia
    Kerr, Anne
    Cunningham-Burley, Sarah
    HEALTH EXPECTATIONS, 2019, 22 (01) : 74 - 82
12345